Faculty profile

Hamed Shateri Najafabadi

ResearcherHuman GeneticsMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.

Hamed Shateri Najafabadi

Researcher

Human Genetics

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
No publications since 2012.
Principal investigator on 7 research grants (4 CIHR, 2 NSERC, 1 SSHRC), most recently in 2022.
Supervised 2 trainees who won CIHR awards, most recently in 2018.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Crc Bioinformatics Cancer Genomics Computational Biology Functional Genomics Gene Regulation Rna Splicing Rna-Binding Proteins

Latest papers

Inhibitors of RNA editing as potential chemotherapeutics against trypanosomatid pathogens.
International journal for parasitology. Drugs and drug resistance · 2012 · senior author
Functional genome annotation by combined analysis across microarray studies of Trypanosoma brucei.
PLoS neglected tropical diseases · 2010 · first author

All 2 publications

Latest funding

Targeting drug tolerant persister cells in poor outcome breast cancer
CIHR · 2024 · Co-investigator
$1,136,025
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
CIHR · 2023 · Co-investigator
$956,250
Générer des contrefactuels pour la biologie moléculaire: une nouvelle approche basée sur des modèles d'apprentissage profond génératifs
NSERC · 2023 · Co-investigator
$90,000

All 14 grants and awards

Targeting drug tolerant persister cells in poor outcome breast cancer

Co-investigatorCIHR2024Project Grant

Principal investigators: Park, Morag

Keywords: Bioinformatics; Chemotherapy-Induced Senescence; Drug Tolerant Persistor Cells; Epigenetics; Patient Derived Xenografts; Patient Minimal Residual Disease; Residual Disease; Spatial Transcriptomics; Triple Negative Breast Cancer

$1,136,025

Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging

Co-investigatorCIHR2023Project Grant

Principal investigators: Soleimani, Vahab D

Keywords: Aging; Cell Biology; Muscle Atrophy; Muscle Stem Cell Biology; Regenerative Medicine; Rejuvenation; Single Cell Technologies; Stem Cell Niche

$956,250

Générer des contrefactuels pour la biologie moléculaire: une nouvelle approche basée sur des modèles d'apprentissage profond génératifs

Co-investigatorNSERC2023Alliance Grants

Principal investigators: Emad, Amin A

Keywords: Counterfactual synthesis; Deep Learning; Generative neural networks; mRNA stability; Perturbation prediction; Single cell transcriptomics

$90,000

Canada Research Chair - Tier 2

Nominated PICIHR2022Canada Research Chairs - CIHR Funded - Tier 2

Principal investigators: Shateri Najafabadi, Hamed

Keywords: Crc

$500,000

Identification of biomarkers using single cell technology that inform on optimal duration of immunotherapy treatment in melanoma

Co-investigatorCIHR2022Project Grant

Principal investigators: Watson, Ian R; Baetz, Tara; Dancey, Janet E; Song, Xinni

Keywords: Image Mass Cytometry; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma Tumor Microenvironment; Single Cell Epigenetic Profiling; Single Cell Sequencing; Single Cell Technology

$1,422,900

Single-cell probing of epigenetic memory in immunity

Co-investigatorCIHR2020Team Grant: Canada-Japan CEEHRC Teams in Advancing Epigenetic Technologies

Principal investigators: Langlais, David

Keywords: 3d Genome; Autoimmunity; Chromosome Conformation Capture; Chronic Inflammation; Epigenetic Reprogramming; Epigenomics; Trained Immunity; Transcription Factor

$300,000

Characterization of oncogenic splicing pathways driven by RNA-binding proteins

Nominated PICIHR2020Project Grant

Principal investigators: Shateri Najafabadi, Hamed

Keywords: Bioinformatics; Cancer Genomics; Computational Biology; Functional Genomics; Gene Regulation; Rna Splicing; Rna-Binding Proteins; Systems Biology; Transcriptomics

$680,850

Understanding the driving forces behind cellular heterogeneity in cancer

Principal investigatorSSHRC2019New Frontiers in Research Fund - Exploration

Principal investigators: Shateri Najafabadi, Hamed

Keywords: Intra-tumour heterogeneity; Gene regulation; Singe-cell RNA-seq; Epigenetics; Systems biology; Statistical modeling; Machine learning

$273,175

Mechanisms of DNA binding and gene regulation by C2H2 zinc finger proteins

Principal investigatorNSERC2018Discovery Grants Program - Individual

Principal investigators: ShateriNajafabadi, Hamed

$287,000

Modelling the regulatory networks that govern mRNA stability and their implication in cancer

SupervisorCIHR2018Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

Principal investigators: Perron, Gabrielle

Keywords: Bioinformatics; Cancer; Computational Biology; Functional Genomics; Gene Regulation; Micro-Rnas; Mrna Stability; Post-Transcriptional Gene Regulation; Rna-Binding Proteins; Transcriptomics

$105,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Hamed Shateri Najafabadi

Research

Latest papers

Latest funding

Inhibitors of RNA editing as potential chemotherapeutics against trypanosomatid pathogens.

Functional genome annotation by combined analysis across microarray studies of Trypanosoma brucei.

Targeting drug tolerant persister cells in poor outcome breast cancer

Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging

Générer des contrefactuels pour la biologie moléculaire: une nouvelle approche basée sur des modèles d'apprentissage profond génératifs

Canada Research Chair - Tier 2

Identification of biomarkers using single cell technology that inform on optimal duration of immunotherapy treatment in melanoma

Single-cell probing of epigenetic memory in immunity

Characterization of oncogenic splicing pathways driven by RNA-binding proteins

Understanding the driving forces behind cellular heterogeneity in cancer

Mechanisms of DNA binding and gene regulation by C2H2 zinc finger proteins

Modelling the regulatory networks that govern mRNA stability and their implication in cancer

Frequent collaborators

Reza Salavati